139 related articles for article (PubMed ID: 22064348)
1. AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia.
Dunne J; Mannari D; Farzaneh T; Gessner A; van Delft FW; Heidenreich O; Young BD; Gascoyne DM
Leukemia; 2012 May; 26(5):1131-5. PubMed ID: 22064348
[No Abstract] [Full Text] [Related]
2. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
[TBL] [Abstract][Full Text] [Related]
3. POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.
Fortier JM; Payton JE; Cahan P; Ley TJ; Walter MJ; Graubert TA
Leukemia; 2010 May; 24(5):950-7. PubMed ID: 20376082
[TBL] [Abstract][Full Text] [Related]
4. JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
Schnittger S; Bacher U; Kern W; Haferlach C; Haferlach T
Leukemia; 2007 Jan; 21(1):183-4. PubMed ID: 17096014
[No Abstract] [Full Text] [Related]
5. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
[No Abstract] [Full Text] [Related]
6. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
Hsiao HH; Sashida G; Kodama A; Fukutake K; Ohyashiki K
Cancer Genet Cytogenet; 2005 May; 159(1):96-7. PubMed ID: 15860366
[No Abstract] [Full Text] [Related]
7. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
8. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
9. Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
Buonamici S; Ottaviani E; Visani G; Bonifazi F; Fiacchini M; Baccarani M; Martinelli G
Haematologica; 2004 Jan; 89(1):103-5. PubMed ID: 14754613
[No Abstract] [Full Text] [Related]
10. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
Licht JD
Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
[No Abstract] [Full Text] [Related]
11. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
[TBL] [Abstract][Full Text] [Related]
12. A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia.
Mannari D; Gascoyne D; Dunne J; Chaplin T; Young B
Leukemia; 2010 Apr; 24(4):891-4. PubMed ID: 20111069
[No Abstract] [Full Text] [Related]
13. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
[TBL] [Abstract][Full Text] [Related]
14. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
15. Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia.
van de Locht LT; Smetsers TF; Wittebol S; Raymakers RA; Mensink EJ
Leukemia; 1994 Oct; 8(10):1780-4. PubMed ID: 7523801
[TBL] [Abstract][Full Text] [Related]
16. Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.
Zhen T; Wu CF; Liu P; Wu HY; Zhou GB; Lu Y; Liu JX; Liang Y; Li KK; Wang YY; Xie YY; He MM; Cao HM; Zhang WN; Chen LM; Petrie K; Chen SJ; Chen Z
Sci Transl Med; 2012 Mar; 4(127):127ra38. PubMed ID: 22461642
[TBL] [Abstract][Full Text] [Related]
17. AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2.
Jiao B; Wu CF; Liang Y; Chen HM; Xiong SM; Chen B; Shi JY; Wang YY; Wang JH; Chen Y; Li JM; Gu LJ; Tang JY; Shen ZX; Gu BW; Zhao WL; Chen Z; Chen SJ
Leukemia; 2009 Sep; 23(9):1598-604. PubMed ID: 19458628
[TBL] [Abstract][Full Text] [Related]
18. A novel variant translocation t(6;8;21)(p22;q22;q22) leading to AML/ETO fusion in acute myeloid leukemia.
Al Bahar S; Adriana Z; Pandita R
Gulf J Oncolog; 2009 Jan; (5):56-9. PubMed ID: 20084788
[TBL] [Abstract][Full Text] [Related]
19. Duplication and triplication of der(21)t(8;21)(q22;q22) in acute myeloid leukemia.
Mikulasovich M; LeBlanc A; Scalise A; Manwani D; Keyzner A; Najfeld V
Cancer Genet Cytogenet; 2009 Jan; 188(2):83-7. PubMed ID: 19100510
[TBL] [Abstract][Full Text] [Related]
20. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO.
Kuchenbauer F; Schnittger S; Look T; Gilliland G; Tenen D; Haferlach T; Hiddemann W; Buske C; Schoch C
Br J Haematol; 2006 Sep; 134(6):616-9. PubMed ID: 16938118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
